debate: should we treat early-stage myelofibrosis? - yes, initiate therapy
Published 8 years ago • 272 plays • Length 12:00
Download video MP4
Download video MP3
Similar videos
-
10:33
debate: should we treat early-stage myelofibrosis? - no, only observe
-
19:54
therapy for “early myelofibrosis”: pros and cons
-
22:06
myelofibrosis prognostic scoring systems: ipss, dipss, dipss-plus, misps, and gipss
-
24:12
debate: survival benefit of jak2 inhibitors in myelofibrosis
-
10:24
debate: high risk myeloma: should it be treated differently? - yes
-
19:02
prognostication and initiation of therapy in polycythemia vera: do we have it right?
-
4:34
what are the considerations when choosing myelofibrosis therapy?
-
14:34
debate: which initial therapy for younger fit patients is best? - cybord and bird
-
12:26
debate: mrd, ready for primetime? - yes
-
14:05
myelofibrosis: emerging jak2 inhibitor combination treatment strategies
-
20:01
primary myelofibrosis - overview (presentation, pathophysiology, investigation, treatment)
-
18:09
diagnosis, prognosis, and therapy of true et vs. prefibrotic mf
-
19:52
treatment option for cytopenic myelofibrosis (mf)
-
2:19
primary vs secondary myelofibrosis | what’s the difference?
-
22:27
influence of mutational status on timing, outcome, and post-transplant management of myelofibrosis
-
21:18
myeloma debate: is mrd ready for prime time? - yes
-
1:02
myelofibrosis: unmet needs
-
5:02
considering a myelofibrosis clinical trial? questions you should ask
-
11:25
debate: to maintain or not to maintain? immunomodulators vs. pi - yes (imids)
Clip.africa.com - Privacy-policy